Key result
A review of 52 literature sources indicated that novel obesity indices, such as the visceral adiposity index and lipid accumulation product, have good predictive ability for cardiometabolic risk.
Why the study?
The study aimed to analyze literature examining the relationship between various obesity indices and cardiometabolic risk.
Do novel obesity indices such as the visceral adiposity index and lipid accumulation product accurately predict cardiometabolic risk?
Do novel obesity indices such as the visceral adiposity index and lipid accumulation product accurately predict cardiometabolic risk?
Novel obesity indices like the visceral adiposity index and lipid accumulation product are useful and simple tools for stratifying patients by cardiometabolic risk.
May improve cardiometabolic risk stratification; leaves open prospective validation before routine use.
Adipose tissue is currently regarded as a key organ for excess dietary lipids, which determine whether the body will maintain normal homeostasis or whether inflammation and insulin resistance will develop. In recent years, there is more information about novel prognostic models — the visceral adiposity index and the lipid accumulation product. The aim of this review was to analyze the results of studies examining the relationship between various indices of obesity and cardiometabolic risk. We analyzed 105 literature sources, 53 of which were ruled out, becausethe processes of interest were not described in detail or included anassessment of the relationship of various obesity indices with metabolic parameters. The results obtained indicate the advisability of using novel obesity indices, which have a good predictive ability and are simple and convenient to use. It is necessary to use additional methods of anthropometric and clinical examination in order to assess the metabolic phenotype of obesity, which will make it possible to stratify patients by the level of cardiometabolic risk.
No takes yet. Share an insight, caveat, or question.
Svarovskaya et al. (2021) conducted a review in Obesity and cardiometabolic risk. Novel obesity indices (visceral adiposity index and lipid accumulation product) was evaluated on Relationship between obesity indices and cardiometabolic risk. A review of 52 literature sources indicated that novel obesity indices, such as the visceral adiposity index and lipid accumulation product, have good predictive ability for cardiometabolic risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: